Occudo Quantitative Strategies LP Amphastar Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$45.51 - $65.0 $752,871 - $1.08 Million	16,543 New	16,543 $760,000
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $565,219 - $632,810	-20,237 Reduced 46.58%	23,213 $650,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $624,592 - $855,528	-22,663 Reduced 34.28%	43,450 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $1.23 Million - $1.75 Million	41,300 Added 166.45%	66,113 $2.3 Million
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $90,049 - $142,956	3,922 Added 18.77%	24,813 $891,000
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $71,816 - $92,205	-3,959 Reduced 15.93%	20,891 $487,000
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $195,060 - $235,100	10,940 Added 78.65%	24,850 $472,000
Q2 2021 Aug 16, 2021	BUY	$17.11 - $20.92 $238,000 - $290,997	13,910 New	13,910 $280,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.